Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$48.94

-3.34 (-6.39%)

06:42
10/18/16
10/18
06:42
10/18/16
06:42

Sarepta initiated with an Outperform at Credit Suisse

Credit Suisse analyst Alethia Young initiated Sarepta with an Outperform and a $68 price target. The analyst has positive expectations on the US EXONDYS 51 launch, confidence of approval and IP settlement in Europe, and success with the Exon 53 program in mid-2017.

  • 06

    Nov

SRPT Sarepta
$48.94

-3.34 (-6.39%)

10/04/16
PIPR
10/04/16
NO CHANGE
Target $68
PIPR
Overweight
Piper Jaffray ups Sarepta target to $68 on Summit deal
Piper Jaffray analyst Edward Tenthoff raised his price target for Sarepta Therapeutics (SRPT) to $68 from $64 after the company licensed Summit Therapeutics' (SMMT) ezutromid to treat Duchenne Muscular Dystrophy in Europe, Turkey and the Commonwealth of Independent States. The deal is a smart way for Sarepta to capitalize on its lead in DMD with the recent FDA approval of Exondys51, Tenthoff tells investors in an intraday research note. His new price target of $68 reflects the value of ezutromid. Tenthoff reiterates an Overweight rating on Sarepta. The stock is up 1% to $61.61 in late morning trading. Summit is up 94%, or $8.17, to $16.82.
10/05/16
ADAM
10/05/16
NO CHANGE
Target $28
ADAM
Buy
Summit Therapeutics price target raised to $28 from $14 at Canaccord
Canaccord analyst Arinda Lee raised her price target on Summit Therapeutics (SMMT) to $28 from $14 following the announcement of its collaboration and licensing agreement with Sarepta Therapeutics (SRPT). The deal calls for Sarepta to gain EU commercialization rights to Summit's pipeline of oral utrophin modulators for all patients with Duchenne muscular dystrophy. Lee reiterated her Buy rating Summit Therapeutics shares.
10/07/16
BARD
10/07/16
NO CHANGE
Target $102
BARD
Outperform
Anthem policy does not mean insurer not covering Sarepta drug, says Baird
Baird analyst Brian Skorney noted Anthem (ANTM) has categorized Sarepta (SRPT) Duchenne muscular dystrophy drug Exondys 51 as "not medically necessary" in a new coverage policy, but he cautions this "does not mean that Anthem is not covering the drug." The analyst explains that the policy means prior authorization requirements may be stricter, but he "highly doubts" that eligible patients will be denied coverage. Skorney, who adds that other large insurers appear to have favorable coverage for the drug, keeps an Outperform rating and $102 price target on Sarepta shares.
10/17/16
JANY
10/17/16
NO CHANGE
JANY
PTC's denial has negative read-through for BioMarin, says Janney Capital
Janney Capital noted that PTC Therapeutics' (PTCT) Translarna and Sarepta's (SRPT) Exondys 51 address non-overlapping DMD populations and there was an expectation of flexibility from the FDA following the conditional approval of Exondys 51. However, the FDA has denied the first appeal of the refuse to file letter regarding PTC's NDA for Translarna for the treatment of nonsense mutation DMD, which the firm said has potential negative read-through for BioMarin's (BMRN) attempt to rekindle Kyndrisa, which is a direct competitor to Sarepta's Exondys 51. The firm added that the news might positively impact reimbursement decisions for Exondys 51.

TODAY'S FREE FLY STORIES

QVCA

QVC Group

$24.61

0.1 (0.41%)

, QVCB

QVC Group

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
FBN Securities media analyst to hold a luncheon meeting »

Media Analyst Routh…

QVCA

QVC Group

$24.61

0.1 (0.41%)

QVCB

QVC Group

LVNTA

Liberty Ventures

$52.69

1.21 (2.35%)

GNCMA

General Communications

$36.81

0.97 (2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 10

    Jul

ICON

Iconix Brand

$6.88

-0.01 (-0.15%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Iconix Brand management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CIR

CIRCOR

$58.61

0.95 (1.65%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
CIRCOR management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CUTR

Cutera

$26.55

1 (3.91%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cutera management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

  • 28

    Sep

EVLV

EVINE Live

$1.02

-0.02 (-1.92%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
EVINE Live management to meet with Craig-Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

FARM

Farmer Bros.

$31.15

1.05 (3.49%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Farmer Bros. management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

AGNC

AGNC Investment

$21.54

-0.16 (-0.74%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
AGNC Investment management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 6/24 Jobless…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

Week of 6/25 Bloomberg…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

NBIX

Neurocrine

$46.77

1.21 (2.66%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Neurocrine management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Jun

CBRL

Cracker Barrel

$167.46

0.74 (0.44%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cracker Barrel management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CRNCY

Cairn Energy

$4.56

0.0998 (2.24%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cairn Energy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

BAYRY

Bayer

$138.99

1.4 (1.02%)

, FMS

Fresenius Medical

$49.19

0.39 (0.80%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
UBS to hold a bus tour »

European Healthcare Bus…

BAYRY

Bayer

$138.99

1.4 (1.02%)

FMS

Fresenius Medical

$49.19

0.39 (0.80%)

RHHBY

Roche

$32.79

0.21 (0.64%)

NVS

Novartis

$85.25

-0.06 (-0.07%)

BPMUF

Basilea Pharmaceutica AG

$84.80

0.45 (0.53%)

GNMSF

Genmab

AZN

AstraZeneca

$34.35

-0.22 (-0.64%)

SHPG

Shire

$171.81

-0.1 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

  • 12

    Jul

  • 13

    Jul

  • 30

    Jul

CSV

Carriage Services

$26.85

0.06 (0.22%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Carriage Services management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 28

    Sep

WM

Waste Management

$73.52

0.41 (0.56%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Waste Management management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

FTV

Fortive

$64.41

1.04 (1.64%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Fortive has a conference call hosted by JPMorgan »

JPMorgan Analyst Tusa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

RGA

Reinsurance Group

$128.86

2 (1.58%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Reinsurance Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SRCL

Stericycle

$77.72

0.48 (0.62%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Stericycle management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 03

    Aug

RVLT

Revolution Lighting

$6.32

-0.05 (-0.78%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Revolution Lighting management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Real GDP to be reported at 08:30 »

Real GDP will be reported…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

Week of 6/28 Fed Balance…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

BIIB

Biogen

$274.64

3.39 (1.25%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Biogen management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 25

    Jul

OXM

Oxford Industries

$62.76

0.92 (1.49%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Oxford Industries management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.